Omvoh: Cost, Dosage, Side Effects, Uses, Interactions, and More

Omvoh (pronounced ahm-VOH) is one of those modern “science is wild” medicines: a targeted biologic that helps calm
the immune system when it’s throwing a never-ending tantrum in the gut. If you’re dealing with moderate to severe
ulcerative colitis or Crohn’s disease, Omvoh may come up in conversations with your gastroenterologistespecially if
other treatments haven’t worked well enough (or stopped working).

This guide breaks down what Omvoh is, what it’s used for, typical dosing schedules, side effects, interactions,
and the big question everyone asks right after “Will it help?”: “How much is this going to cost me?”
It’s written for everyday humans (not robot pharmacists), but it’s still based on real, label-level information.

Important: Omvoh is a prescription medication for adults. This article is educational and
not a substitute for medical advice. Your clinician is the final boss of dosing decisions.

What Is Omvoh (mirikizumab-mrkz)?

Omvoh is the brand name for mirikizumab-mrkz, a biologic medicine (specifically, a monoclonal antibody).
It works by targeting interleukin-23 (IL-23), a signaling protein that can drive inflammation in certain
immune-related diseases. If IL-23 is acting like the group chat that keeps hyping up inflammation, Omvoh is the person
who mutes the thread.

Because it changes immune signaling, Omvoh can reduce inflammation in the digestive tracthelping some people reach
remission or at least significantly reduce symptoms like diarrhea, urgency, abdominal pain, and rectal bleeding.

Uses: What Conditions Does Omvoh Treat?

FDA-approved uses

Omvoh is indicated for treating:

• Moderately to severely active ulcerative colitis in adults
• Moderately to severely active Crohn’s disease in adults

What “moderate to severe” usually means in real life

Your care team typically considers Omvoh when symptoms significantly affect daily life, when inflammation is confirmed
through labs/endoscopy/imaging, and/or when other therapies (like corticosteroids, immunomodulators, or other biologics)
haven’t done enough. Sometimes it’s used after anti-TNF drugs, sometimes after gut-selective biologics, and sometimes
because it fits your specific risk profile or lifestyle.

How Omvoh Is Given (Infusion First, Then Injections)

Omvoh has a two-phase approach that can feel a little like “starter mode” and then “maintenance mode”:

• Induction phase: You receive Omvoh as an intravenous (IV) infusion in a clinic or
  infusion center.
• Maintenance phase: You switch to subcutaneous injections (under the skin), often at
  home after training.

This structure is common with IBD biologics: induction is designed to bring inflammation down, and maintenance is meant
to keep things steady over time.

Omvoh Dosage (Typical Schedules)

Dosing is condition-specific, and your clinician may adjust timing based on response, safety labs, and your overall
treatment plan. The schedules below reflect the standard adult dosing used in prescribing information.

Ulcerative colitis dosage

• Induction: 300 mg IV at Week 0, Week 4, and Week 8.
  Each infusion is given over at least 30 minutes.
• Maintenance: Starting at Week 12, 200 mg injected
  subcutaneously every 4 weeks.
  This may be given as one 200 mg injection or two 100 mg injections back-to-back,
  depending on the device/formulation available.

Crohn’s disease dosage

• Induction: 900 mg IV at Week 0, Week 4, and Week 8.
  Each infusion is given over at least 90 minutes.
• Maintenance: Starting at Week 12, 300 mg injected
  subcutaneously every 4 weeks.
  The 300 mg dose is typically given as two consecutive injections (a 100 mg and a 200 mg injection).

What if you miss a dose?

Because Omvoh is a biologic used to manage chronic inflammation, timing matters. If a dose is missed, the safest move is
to contact your prescribing clinic for instructions rather than improvising a “double-up” plan. (Your gut does not need
surprise plot twists.)

Before Starting Omvoh: Screening and Prep Your Clinician May Do

Since Omvoh affects immune function, prescribers commonly check a few things before the first infusion:

• Tuberculosis (TB) screening (because immune-modulating therapy can raise infection risks)
• Baseline liver enzymes and bilirubin (because liver injury is a listed safety concern)
• Vaccination status (because certain vaccines are not recommended during treatment)

If you have an active infection, treatment may be delayed until it’s resolved. If you have a history of recurring
infections, your clinician will weigh benefits vs. risks.

Side Effects of Omvoh

Most side effects reported with Omvoh are mild to moderate, butlike any immune-targeting biologicthere are also
potentially serious risks that are important to understand.

Common side effects

Side effects can vary by individual and by condition studied, but commonly reported ones include:

• Upper respiratory infections (think: cold-like symptoms)
• Injection site reactions (redness, pain, swelling, itching)
• Joint pain (arthralgia)
• Headache
• Rash
• Herpes viral infections (in some people)

Serious risks and warnings to know

• Serious allergic (hypersensitivity) reactions: Rare, but can happenespecially around IV infusions.
  Seek urgent care for symptoms like severe hives, swelling, or trouble breathing.
• Infections (including TB): Omvoh can lower the immune system’s ability to fight infections.
  Notify your clinician promptly if you develop persistent fever, worsening cough, shortness of breath, or other signs
  your care team has flagged.
• Liver injury (hepatotoxicity): Your clinic may monitor liver tests during treatment.
  Contact your clinician quickly if you notice symptoms that could suggest liver problems (for example: yellowing of the
  skin/eyes, dark urine, unusual fatigue, or persistent nausea).

If you’re thinking, “Wow, immune system meds sound serious,” that’s… a fair reaction. The upside is that monitoring and
screening exist for a reason: to catch issues early and keep the benefit-risk balance in your favor.

Omvoh Interactions

Vaccine interactions (a big one)

Omvoh has an important interaction category: live vaccines. Live vaccines are generally not recommended
during Omvoh treatment (and timing around starting/stopping therapy matters too). If you might need a live vaccine,
discuss it with your clinician ahead of time.

For non-live vaccines, your clinician may still recommend staying up-to-date, but immune response may not be fully known
for every vaccine scenario. Always tell vaccine providers you’re taking Omvoh.

Drug-drug interactions

Omvoh is a monoclonal antibody, not a pill processed heavily through liver enzymes like many traditional drugs. That means
it’s less likely to have classic “don’t take with grapefruit” interactions. In pharmacokinetic analyses, Omvoh
clearance wasn’t meaningfully impacted by common IBD background meds like aminosalicylates, corticosteroids, or certain
oral immunomodulators.

Also, in interaction research using common drug-metabolizing enzyme (CYP) “test” medications, mirikizumab didn’t show
meaningful changes in exposure for several representative drugs. Translation: major CYP-based drug interactions are not
expected to be a headline issue.

But here’s the practical caveat

Even if Omvoh doesn’t “interact” in the classic pharmacy sense, combining immune-modulating therapies can increase
infection risk. So if you’re on other biologics or potent immunosuppressants, your clinician will coordinate the plan
carefully rather than stacking treatments like they’re building a sandwich.

Omvoh Cost: What You Might Pay (and Why It Varies So Much)

Let’s talk moneybecause biologics are incredible, and also expensive enough to make your wallet consider moving to a
different country.

List price vs. real-world price

The list price (sometimes called wholesale acquisition cost) is a reference point, not what most insured
patients pay out of pocket. Your actual cost depends on your insurance coverage, whether the dose is billed under medical
benefits (infusions) or pharmacy benefits (self-injections), your deductible, coinsurance, and the site of care.

As examples of publicly available pricing references:

• Manufacturer pricing pages publish list-price figures for Omvoh infusion and injection presentations.
• Consumer drug-price resources may list retail/cash prices that can be in the five figures for a
  month’s supply (or more), depending on the form and pharmacy.

Hidden cost factor: infusion administration

Induction doses are administered by IV infusion, which may involve additional facility or administration fees. Even if the
medication is covered, infusion billing can change the out-of-pocket picture depending on your plan.

Ways people reduce out-of-pocket costs

• Manufacturer savings programs: For eligible commercially insured patients, copay programs may reduce
  per-treatment costs dramatically.
• Patient assistance programs: Nonprofit or manufacturer-supported programs may help qualifying patients
  with financial need obtain medication at low or no cost.
• Prior authorization support: Many plans require proof of diagnosis and previous treatment history.
  Gastroenterology offices are used to this paperwork (it’s practically a second language).
• Site-of-care planning: Sometimes infusion location choices affect cost (hospital outpatient vs
  standalone infusion center), depending on insurance rules.

Quick reality check: Government insurance programs often have different rules, and some manufacturer
copay cards don’t apply. Your clinic’s financial counselor or specialty pharmacy team can be a surprisingly powerful ally.

Storage and Handling (Because Biologics Are Picky)

Omvoh is typically stored refrigerated and protected from light. It should not be frozen or shaken.
Some formulations may be allowed at room temperature for a limited time (in the original carton) depending on the
product instructions you receive.

Practical tip: set up a “medication zone” in your fridge where it won’t get shoved behind the leftover pizza and forgotten
until it becomes a science fair project.

How Long Does Omvoh Take to Work?

Response time varies. Some people notice symptom improvements within weeks, while others need a longer runway.
In inflammatory bowel disease, clinicians often evaluate response using a combo of symptoms, lab markers, and sometimes
endoscopic findingsbecause feeling better is great, but healing inflammation is the actual win.

Frequently Asked Questions

Is Omvoh a steroid?

No. Omvoh is a biologic monoclonal antibody that targets IL-23. It’s not a corticosteroid and doesn’t have the same side
effect profile as long-term steroid use.

Can I drink alcohol while taking Omvoh?

Alcohol isn’t known for a direct “dangerous combo” interaction with Omvoh the way it is with some medications. However,
because Omvoh has a liver-related warning and because alcohol can irritate GI symptoms for some people, it’s smart to ask
your clinician what’s reasonable for your specific situation.

Does Omvoh cause weight gain?

Weight gain isn’t typically highlighted as a direct medication effect. That said, if your disease control improves and your
appetite returns, your weight may changesometimes in a positive “I can finally eat again” way. Unexplained weight loss,
on the other hand, can be a sign of uncontrolled disease or infection and should be discussed with a clinician.

Real-World Experiences: What People Often Notice (Anecdotal)

Clinical trials tell us what happens on average under carefully controlled conditions. Real life is… less controlled.
People’s experiences with Omvoh vary widely, but some themes come up often when patients talk about starting a biologic
with an infusion-to-injection schedule.

The induction phase feels “official.” Many patients describe the first three infusions as a psychological
shift: you’re not just “trying another med,” you’re entering the Biologic Era. Infusion centers can feel oddly comforting
(snacks, warm blankets, a chair that reclines like it’s auditioning for a nap commercial), but it also takes planning
time off work, transportation, and scheduling around family life. A common tip is to treat infusion days like appointments
with your future self: bring a charger, water, a book, and the kind of sweater that says, “I came prepared.”

Then comes the switch to injections. Some people love the independence of at-home dosing. Others need a
few rounds before “self-injection” stops sounding like a plot point from an action movie. Patients often report that the
training matters: learning where to inject, how to rotate sites (abdomen, thigh, upper arm), and how to avoid injecting
into irritated or bruised skin. A practical trick that many injection users adopt (for various biologics) is letting the
device sit out briefly so it’s not ice-cold at the moment of injectionalways following the product instructions and
clinic guidance.

Side effects: usually mild, but people pay attention to infections. In everyday conversation, the most
common “annoyances” reported tend to be cold-like symptoms, headache, and injection-site irritation. Some people mention
a few days of feeling run-down after an infusion or injection, while others feel nothing noticeable. The bigger concern
patients talk about is infection vigilance: “Is this just a regular cold, or do I call my doctor?” Many clinics give clear
guidance on what symptoms should trigger a callespecially fever that doesn’t go away, persistent cough, or anything that
feels unusual for you. When patients feel supported with a simple checklist, anxiety tends to drop.

Monitoring becomes part of the routine. People often mention getting used to lab checks, especially early
on. It can feel annoyinguntil you reframe it as your care team running diagnostics like a pit crew: quick checks that
keep the engine running safely. Some patients keep a notes app log of injection dates, symptom changes, bowel patterns,
and energy levels. That record can make follow-up visits more productive than the classic “How have you been?”
“Uh… weird?” exchange.

Cost navigation can be as stressful as symptomsuntil it’s not. A surprisingly common experience is that
the hardest part isn’t the needleit’s the insurance process. People describe prior authorizations, “specialty pharmacy”
phone calls, and benefit investigations like a mini side quest. The good news is that many gastroenterology clinics have
staff who deal with this every day, and manufacturer support programs may help eligible patients reduce out-of-pocket
costs. Patients who feel most successful often do two things: (1) they respond quickly to paperwork requests, and (2)
they ask for help early rather than waiting until a dose is delayed.

The most meaningful “experience” is symptom change. When Omvoh works well, people often talk about
everyday wins: fewer urgent bathroom trips, less pain, less fear about leaving the house, and the ability to plan meals
and travel without doing advanced reconnaissance on restroom locations. Not everyone responds the same way, and some
people switch therapies if results aren’t strong enough. But for responders, the improvement can feel less like a dramatic
miracle and more like getting their normal life backquietly, steadily, and with fewer interruptions from their gut.

Bottom Line

Omvoh is an IL-23–targeting biologic used in adults with moderately to severely active ulcerative colitis or Crohn’s
disease. It typically starts with three IV infusions (induction) and then continues with subcutaneous injections
(maintenance). The biggest safety topics include infections (including TB), allergic reactions, and liver-related
monitoring, plus vaccine timingespecially avoiding live vaccines during treatment.

Cost can be high, but real-world out-of-pocket expense depends heavily on insurance and available savings or assistance
programs. If Omvoh is on your treatment radar, the best next step is a practical one: ask your clinic for a clear plan
covering dosing schedule, monitoring, vaccine timing, and financial support options.